Skye Bioscience (SKYE) Shares Outstanding (2012 - 2026)
Skye Bioscience (SKYE) recorded Shares Outstanding of 4.96 million in Q2 2026, up 0.1% from 4.96 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Shares Outstanding (2012 - 2026) Analysis & Trends
Starting with Q2 2012, Skye Bioscience's Shares Outstanding history includes 57 quarters.
- Annual Shares Outstanding has increased for 12 straight years, with a five-year compound annual growth rate of 112.1% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 4.56 million in FY2024 (+420.8%), 875,755 in FY2023 (+215.4%), 277,635 in FY2022 (+36.6%) and 203,300 in FY2021 (+76.2%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding in data going back to Q2 2012.
- On a year-over-year basis, Shares Outstanding has increased for 45 consecutive quarters, with growth averaging 108.6% over the last eight quarters.
- The year-over-year growth in Shares Outstanding has ranged between 0.1% (Q1 2026) and 895.0% (Q2 2024) over the last five years.
- Per Business Quant, the preceding three quarters came in at 4.96 million (Q1 2026), 4.96 million (Q4 2025) and 4.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 4.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.96 Mn |
| Mar 31, 2026 | 4.96 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 4.96 Mn |
| Jun 30, 2025 | 4.96 Mn |
| Mar 31, 2025 | 4.96 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 875,755.00 |
| Sep 30, 2023 | 985,068.00 |
| Jun 30, 2023 | 485,775.00 |
| Mar 31, 2023 | 470,947.00 |
| Dec 31, 2022 | 277,635.00 |
| Sep 30, 2022 | 247,963.00 |
| Jun 30, 2022 | 247,963.00 |
| Mar 31, 2022 | 247,912.00 |
| Dec 31, 2021 | 203,300.00 |
| Sep 30, 2021 | 206,745.00 |
API Access
Skye Bioscience Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();